Exton, Pennsylvania, Oct. 04, 2023 (GLOBE NEWSWIRE) Prior to the initial approval of Benlysta in 2011, systemic lupus erythematosus (SLE) patients and prescribers had limited options for the management
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) said that the European Commission has approved Saphnelo (anifrolumab) as an add-on therapy for the treatment of adult patients with moderate to severe